CDC25A and colonic neoplasm: It appears that miR-21 targets multiple tumour-supressive pathways[31] and recent studies showed convincing evidence that miR-21 negatively regulates Cdc25A and cell cycle progression in colon cancer[37] and in human glioblastoma cells[38].